Tango Therapeutics, Inc. ($TNGX)
Filing Information
| Accession Number | 0001193125-26-159747 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 17, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
115,380
Total Value
$1,161,492.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D | Common Stock | โ | Apr 15, 2026 | Exercise/Conversion | 38,460 | $5.20 | $199,992.00 | 151,082 | Direct | โ | View Details | |
President, R&D | Common Stock | โ | Apr 15, 2026 | Sale | 38,460 | $25.00 | $961,500.00 | 112,622 | Direct | โ | View Details | |
President, R&D | Stock Option (Right to Buy) | Derivative | Apr 15, 2026 | Exercise/Conversion | 38,460 | $0.00 | $0.00 | 395,040 | Direct | โ | View Details |